Krystexxa Trademark Details

Krystexxa was registered on Tuesday, February 15, 2011 and is currently owned by Crealta Pharmaceuticals LLC under the registration number 3920201 . This mark is alive with a status of Registered. The last case file activity for this mark occured 13 years ago on Tuesday, February 15, 2011, according to the United State Patent & Trademark Office
Word Mark Krystexxa
Status Alive Registered 700 — Registered

Current Owner

Crealta Pharmaceuticals LLC of Lake Forest, IL

View all trademarks for Crealta Pharmaceuticals LLC
Other Trademarks for Crealta Pharmaceuticals LLC

Previous Owners

Savient Pharmaceuticals, Inc. of East Brunswick, NJ

View all trademarks for Savient Pharmaceuticals, Inc.
Other Trademarks for Savient Pharmaceuticals, Inc.

Horizon Pharma Rheumatology LLC of Lake Forest, IL

View all trademarks for Horizon Pharma Rheumatology LLC
Serial Number 77552516
Registration Number 3920201
Status Date Tuesday, February 15, 2011
Filing Date Tuesday, February 15, 2011
Registration Date Tuesday, February 15, 2011
Attorney Carole E. Klinger

Correspondent

CAROLE E. KLINGER
KRAMER LEVIN NAFTALIS & FRANKEL LLP
1177 AVENUE OF THE AMERICAS
NEW YORK, NY 10036-2714

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of elevated levels of uric acid in the body and/or body fluids; biological and pharmaceutical preparations for the treatment of rheumatological conditions

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, August 26, 2008
First Use Anywhere Tuesday, November 30, 2010
First Use In Commerce Thursday, December 9, 2010
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.